Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer

NCT00343109 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Breast Cancer
Male Breast Cancer
Stage IIIB Breast Cancer
Stage IIIC Breast Cancer
Stage IV Breast Cancer

Interventions

BIOLOGICAL: HER-2/neu intracellular domain protein
PROCEDURE: leukapheresis
OTHER: laboratory biomarker analysis
BIOLOGICAL: sargramostim
OTHER: immunologic technique
BIOLOGICAL: synthetic tumor-associated peptide vaccine therapy

Sponsor

University of Washington

Collaborators

[object Object]